|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Pioneer Surgical Technology, a leading innovator in the design and manufacture of spinal and orthopedic implants. |
|---|---|
| Transferring Party | Encelle, Inc., a developer of sterile, injectable biopolymers designed to repair or regenerate diseased or damaged tissue. |
| Sector | Medical Devices |
| Date | June 4, 2007 |
| Analysis Allows Pioneer to enter $1.2b orthobiologics market. The 2 companies had an R&D collaboration for the development of a family of products to assist in the repair and regeneration of bone and soft tissue, initially focused on spinal fusion. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |